NEW YORK (GenomeWeb) – Cancer molecular diagnostics firm Empire Genomics announced today that it has signed a distribution deal for its products in China with contract research organization HemaTone Beijing.

Growing demand in the region for cancer diagnostics was the impetus for the deal, which is expected to bring in more than $5 million in revenues for Empire over the five-year term of the agreement, the company said. HemaTone will distribute Empire's personalized diagnostic testing products in China, and will provide product training and marketing support to its clients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.